Cargando…
Fighting against frailty and sarcopenia – As well as COVID-19?
Autores principales: | Ekiz, Timur, Kara, Murat, Özçakar, Levent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7263226/ https://www.ncbi.nlm.nih.gov/pubmed/32505075 http://dx.doi.org/10.1016/j.mehy.2020.109911 |
Ejemplares similares
-
Letter to the editors in response to: Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may be harmful in patients with diabetes during COVID-19 pandemic (Cure et al.)
por: Ekiz, Timur, et al.
Publicado: (2020) -
Measuring grip strength in COVID-19: A simple way to predict overall frailty/impairment
por: Ekiz, Timur, et al.
Publicado: (2020) -
Obesity paradox in sarcopenia and knee osteoarthritis: comment on the article by Andrews et al
por: Mezian, Kamal, et al.
Publicado: (2021) -
Neuralgic amyotrophy associated with COVID-19 infection: the broken bough
por: Doğan, Yahya, et al.
Publicado: (2022) -
‘Scientific Strabismus’ or two related pandemics: coronavirus disease and vitamin D deficiency
por: Kara, Murat, et al.
Publicado: (2020)